News
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Provides Information Regarding Inka Health's USPTO Provisional Patent Application for AI-Powered Precision Medicine Platform, SynoGraph
Onco-Innovations subsidiary, Inka Health, files patent for AI platform SynoGraph, enhancing precision medicine and oncology drug development. SynoGraph leverages AI-driven causal inference for treatment optimization -
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Announces U.S. Listing on the OTCQB Market
Onco-Innovations Limited announces commencement of trading on OTCQB marketplace under symbol 'ONNVF', enhancing visibility for U.S. investors. Company remains listed on the Canadian Securities Exchange under symbol 'ONCO' -
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Announces Expression of Interest Between Inka Health and Global Data Leader, Quantify Research
Onco-Innovations' Inka Health Corp. enters Expression of Interest with Quantify Research for collaboration in advanced data analytics and oncology research to enhance cancer treatment insights -
-
